Skip to main content
. 2019 Dec 14;8(4):297. doi: 10.3390/pathogens8040297

Figure 7.

Figure 7

BV-2-derived EV treatment decreases cell viability. BV-2 cells in exosome-free medium were treated with BV-2-derived and P. aeruginosa-derived EVs at 10 µg/mL or 40 µg/mL for 72 h. Cell viability was assessed by trypan blue exclusion assay. The mean values for five independent experiments are presented as fold changes. The results are presented as mean ± SEM values.